Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Flavopiridol in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies
| Conditions: | Cancer |
| Start Date: | October 1, 2003 |
| Phase: | Phase I |
| Status: | Suspended |
| NCT ID: | NCT00070239 |
| Study Type: | Interventional |
| Intervention: | Drug: alvocidib |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Dana-Farber Cancer Institute|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 80 |
| Funded By: | Other|NIH |
| First Received: | October 3, 2003 |
| End Date: | |
| Last Updated: | March 13, 2010 |
| Last Verified: | June 1, 2008 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
